| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Aug―05 |
The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment |
Zoe M. Weinstein, Kara M. Magane, Sara Lodi, Alicia S. Ventura, Angela R. Bazzi, Juliana Blodgett, Sarah Fielman, Melissa Davoust, Margaret G. Shea, Clara A. Chen, Anna Cheng, Jacqueline Theisen, Samantha Blakemore, Richard Saitz |
| 2 |
[GO] |
2024―Mar―13 |
Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum |
|
| 3 |
[GO] |
2024―Feb―12 |
North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes during the COVID-19 Pandemic |
Phillip M. Hughes, Caleb W. Easterly, Kathleen C. Thomas, Christopher M. Shea, Marisa Elena Domino |
| 4 |
[GO] |
2023―Sep―26 |
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients |
Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai |
| 5 |
[GO] |
2023―Sep―26 |
Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States |
Ashley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens |
| 6 |
[GO] |
2023―Aug―11 |
Telehealth-delivered Psychotherapy for the Treatment of Alcohol Use Disorder: Patient Perspectives in the Age of COVID-19 |
Rachel Girard, Jane Foreman, Ellen Pinnette, Erin E. Bonar, Anne Fernandez, Lewei (Allison) Lin |
| 7 |
[GO] |
2023―Aug―11 |
Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic |
Kenneth Lee, Yue Zhao, Tazmin Merali, Christopher Fraser, Jan-Marie Kozicky, Marie-Christine Mormont, Brian Conway |
| 8 |
[GO] |
2023―Mar―31 |
Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial |
Babak Tofighi, Beita Badiei, Ryan Badolato, Crystal Fuller Lewis, Edward Nunes, Anil Thomas, Joshua D. Lee |
| 9 |
[GO] |
2023―Mar―10 |
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van |
Omeid Heidari, Katie J. O’Conor, Diane Meyer, Victoria Cargill, Kelly Lowensen, Jason E. Farley |
| 10 |
[GO] |
2023―Mar―02 |
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation |
Aline M. Lott, Anissa N. Danner, Carol A. Malte, Emily C. Williams, Adam J. Gordon, Max A. Halvorson, Andrew J. Saxon, Hildi J. Hagedorn, George G. Sayre, Eric J. Hawkins |
| 11 |
[GO] |
2023―Feb―02 |
Individuals Reporting Past 3-month Smoked Stimulant Use Are Placed at Risk for Infection and Injury Amid COVID-19 |
Dinah Applewhite, Susan Regan, Sarah Mackin, Clare Schmidt, Jim Duffy, Kenneth Washington, Nathaneal Micklos, Sarah Casey, Samantha Sawyer, Laura Kehoe, Sydney Howard, Giovanie Yacorps, Sarah E. Wakeman |
| 12 |
[GO] |
2023―Feb―02 |
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents |
Grace Noonan, Jason Glenn |
| 13 |
[GO] |
2023―Feb―02 |
Assessment of COVID-19-Driven Changes in an Integrated OBGYN-Addiction Treatment Clinic and Future Implications |
Sumaya Smarony, Anna Beth Parlier-Ahmad, Hannah Shadowen, Bhushan Thakkar, Marjorie O. Scheikl, Caitlin E. Martin |
| 14 |
[GO] |
2023―Feb―02 |
Pregnancy, Opioid Use Disorder and COVID-19: An Evaluation of Acute Care Presentations During a Pandemic |
Elizabeth Gill, Anupa D. Ghimire, Derek A. Robinett, James S. Booth, Lauren A. Walter |
| 15 |
[GO] |
2022―Oct―18 |
Struggling With Recovery From Opioids: Who Is at Risk During COVID-19? |
Diana R. Keith, Allison N. Tegge, Jeffrey S. Stein, Liqa N. Athamneh, William H. Craft, Howard D. Chilcoat, Anne Le Moigne, Angela DeVeaugh-Geiss, Warren K. Bickel |
| 16 |
[GO] |
2022―Sep―21 |
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19 |
Melissa N. Poulsen, William Santoro, Roseanne Scotti, Catherine Henderson, Meaghan Ruddy, Angela Colistra |
| 17 |
[GO] |
2022―Sep―09 |
Increased Difficulties Managing Chronic Medical Conditions During the COVID-19 Pandemic Are Associated With Increased Alcohol and Cannabis Use Among Unhoused and Unstably Housed Women |
Elise D. Riley, Leah Warner, Judith A. Hahn, Carl Braun, Samantha Dilworth, Barry Zevin, Torsten B. Neilands, Sheri D. Weiser |
| 18 |
[GO] |
2022―Aug―02 |
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report: Erratum |
|
| 19 |
[GO] |
2022―Aug―02 |
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine |
Maria A. Corcorran, Elizabeth J. Austin, Czarina N. Behrends, Elsa S. Briggs, Madeline C. Frost, Alexa M. Juarez, Noah D. Frank, Elise Healy, Stephanie M. Prohaska, Paul A. LaKosky, Shashi N. Kapadia, David C. Perlman, Bruce R. Schackman, Don C. Des Jarlais, Emily C. Williams, Sara N. Glick |
| 20 |
[GO] |
2022―Jul―21 |
Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey |
Carolina Barbosa, William N. Dowd, Alan Barnosky, Katherine J. Karriker-Jaffe |
| 21 |
[GO] |
2022―Jul―15 |
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later |
Amy J. Kennedy, James S. George, Gina Rossetti, Christopher O. Brown, Kyle Ragins, David Dadiomov, Rebecca Trotzky-Sirr, Gloria Sanchez, Herman Llamas, Brian Hurley |
| 22 |
[GO] |
2022―Jul―07 |
COVID-19 Vaccination Status and Concerns Among People Who Use Drugs in Oregon |
Erin Stack, Sarah Shin, Kate LaForge, Justine Pope, Gillian Leichtling, Jessica E. Larsen, Mikaela Byers, Judith M. Leahy, Daniel Hoover, Laura Chisholm, P. Todd Korthuis |
| 23 |
[GO] |
2022―Jun―24 |
Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis |
Jarratt D. Pytell, Ashish P. Thakrar, Geetanjali Chander, Elizabeth Colantuoni |
| 24 |
[GO] |
2022―Mar―11 |
HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic During a Local HIV Outbreak at the Onset of the COVID-19 Pandemic |
Hannan M. Braun, Chelsea Walter, Natalija Farrell, Katie B. Biello, Jessica L. Taylor |
| 25 |
[GO] |
2022―Feb―23 |
Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment During COVID-19 |
Ji Eun Chang, Zoe Lindenfeld, Tatiana Thomas, Justine Waldman, Judith Griffin |
| 26 |
[GO] |
2022―Feb―15 |
Changes in Cannabis Use Risk Behaviors During the First and Second COVID-19 Lockdown in Israel |
Sharon R. Sznitman |
| 27 |
[GO] |
2022―Feb―15 |
Shifting Medication Treatment Practices in the COVID-19 Pandemic |
Noa Krawczyk, Hannah Maniates, Eric Hulsey, Jennifer S. Smith, Ellen DiDomenico, Elizabeth A. Stuart, Brendan Saloner, Sachini Bandara |
| 28 |
[GO] |
2022―Feb―12 |
Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs |
Ran Ha Hong, Rupinder Brar, Nadia Fairbairn |
| 29 |
[GO] |
2022―Feb―04 |
A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic |
Alyssa F. Peterkin, Rohit Abraham, Miriam T.H. Harris |
| 30 |
[GO] |
2022―Jan―12 |
Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic |
Minhee L. Sung, Anne C. Black, Derek Blevins, Brandy F. Henry, Kathryn Cates-Wessel, Michael A. Dawes, Karen Drexler, Holly Hagle, Todd Molfenter, Frances R. Levin, William C. Becker, E. Jennifer Edelman |
| 31 |
[GO] |
2021―Nov―18 |
Factors Associated With Increased Opioid Use During the COVID-19 Pandemic |
Tea Rosic, Leen Naji, Nitika Sanger, David C. Marsh, Andrew Worster, Lehana Thabane, Zainab Samaan |
| 32 |
[GO] |
2021―Jun―26 |
During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio |
Jamie Vieson, Arthur B. Yeh, Qizhen Lan, Jon E. Sprague |
| 33 |
[GO] |
2021―Jun―19 |
Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing |
Nabila El-Bassel, Karli R. Hochstatter, Melissa N. Slavin, Chenghao Yang, Yudong Zhang, Smaranda Muresan |
| 34 |
[GO] |
2021―May―04 |
The Role of Alcohol Biomarkers in Detecting a Physician's COVID-19-Related Acute Stress Response |
Alexis G. Polles, William S. Jacobs, Chad Brazle, Lisa J. Merlo |
| 35 |
[GO] |
2021―Apr―26 |
Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties |
Yuhui Zhu, Zhe Fei, Larissa J. Mooney, Kaitlyn Huang, Yih-Ing Hser |
| 36 |
[GO] |
2021―Apr―20 |
Opioid-related Emergency Department Visits During COVID-19 in a Large Health System |
Gavin T. Hall, Daniel S. Cruz, Patrick M. Lank, Danielle M. McCarthy, Howard S. Kim |
| 37 |
[GO] |
2021―Apr―20 |
Virtual Twelve Step Meeting Attendance During the COVID-19 Period |
Marc Galanter, William L. White, Brooke Hunter |
| 38 |
[GO] |
2021―Apr―12 |
Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic |
Emily Gleason, Nathanial S. Nolan, Laura R. Marks, Tracey Habrock, Stephen Y. Liang, Michael J. Durkin |
| 39 |
[GO] |
2021―Mar―26 |
The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic |
Chao-Ying Chen, I-Hua Chen, Wen-Li Hou, Marc N. Potenza, Kerry S. O’Brien, Chung-Ying Lin, Janet D. Latner |
| 40 |
[GO] |
2021―Mar―24 |
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic |
Lila Flavin, Babak Tofighi, Noa Krawczyk, Daniel Schatz, Jennifer McNeely, Jenna Butner |
| 41 |
[GO] |
2021―Feb―27 |
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19 |
Ximena A. Levander, Haven Wheelock, Justine Pope, Abby Lee, Kerith Hartmann, Sarah Abuelkhair, Jessica L. Gregg, Bradley M. Buchheit |
| 42 |
[GO] |
2021―Feb―21 |
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis |
Andrew S. Huhn, Eric C. Strain, Jasmyne Jardot, Gavin Turner, Cecilia L. Bergeria, Sandeep Nayak, Kelly E. Dunn |
| 43 |
[GO] |
2021―Feb―21 |
Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication |
John W. McIlveen, Kim Hoffman, Kelsey C. Priest, Dongseok Choi, Phillip Todd Korthuis, Dennis McCarty |
| 44 |
[GO] |
2021―Feb―06 |
Factors Associated With Drug Overdoses During the COVID-19 Pandemic |
Alexandra M. Mellis, Braeden C. Kelly, Marc N. Potenza, Jessica N. Hulsey |
| 45 |
[GO] |
2020―Dec―15 |
Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19 |
A. Taylor Kelley, Matthew T. Dungan, Adam J. Gordon |
| 46 |
[GO] |
2020―Dec―15 |
COVID-19 and Cannabidiol (CBD) |
Jag H. Khalsa, Greg Bunt, Sanjay B. Maggirwar, Shyam Kottilil |
| 47 |
[GO] |
2020―Dec―15 |
Cannabis Use During the COVID-19 Pandemic in Canada |
Sameer Imtiaz, Samantha Wells, Jürgen Rehm, Hayley A. Hamilton, Yeshambel T. Nigatu, Christine M. Wickens, Damian Jankowicz, Tara Elton-Marshall |
| 48 |
[GO] |
2020―Dec―15 |
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia |
Sally M. Gainsbury, Thomas B. Swanton, Martin T. Burgess, Alex Blaszczynski |
| 49 |
[GO] |
2020―Dec―15 |
COVID-19 Social Distancing and Online Mutual Help Engagement for Alcohol Use Recovery |
Jason B. Colditz, Scott D. Rothenberger, Jane M. Liebschutz, Bruce L. Rollman, Kevin L. Kraemer |
| 50 |
[GO] |
2020―Dec―10 |
Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic |
Miriam Komaromy, Mary Tomanovich, Jessica L. Taylor, Glorimar Ruiz-Mercado, Simeon D. Kimmel, Sarah M. Bagley, Kelley M. Saia, Eileen Costello, Tae Woo Park, Colleen LaBelle, Zoe Weinstein, Alexander Y. Walley |
| 51 |
[GO] |
2020―Nov―24 |
Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic |
Darlene Santiago Quiñones, Kyle Melin, Luis Roman, Francisco Rodriguez, Jose Alvarado, Carlos E. Rodríguez-Díaz |
| 52 |
[GO] |
2020―Nov―19 |
The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose |
Alexandra B. Collins, Francesca L. Beaudoin, Elizabeth A. Samuels, Rachel Wightman, Janette Baird |
| 53 |
[GO] |
2020―Nov―11 |
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic |
Courtney D. Nordeck, Megan Buresh, Noa Krawczyk, Michael Fingerhood, Deborah Agus |
| 54 |
[GO] |
2020―Nov―06 |
The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities |
Erin Stack, Gillian Leichtling, Jessica E. Larsen, Mary Gray, Justine Pope, Judith M. Leahy, Lillian Gelberg, Andrew Seaman, Philip Todd Korthuis |
| 55 |
[GO] |
2020―Nov―04 |
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies |
Derek D. Satre, Esti Iturralde, Murtuza Ghadiali, Kelly C. Young-Wolff, Cynthia I. Campbell, Amy S. Leibowitz, Stacy A. Sterling |
| 56 |
[GO] |
2020―Oct―26 |
Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19 |
Erin L. Winstanley, Laura R. Lander, Wanhong Zheng, Kari-Beth Law, Ashley Six-Workman, James H. Berry |
| 57 |
[GO] |
2020―Oct―26 |
Alcohol Consumption in Response to the COVID-19 Pandemic in the United States |
Carolina Barbosa, Alexander J. Cowell, William N. Dowd |
| 58 |
[GO] |
2020―Oct―08 |
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic |
David C. Cone, Sandy Bogucki, Kevin Burns, Gail D’Onofrio, Kathryn Hawk, Daniel Joseph, David A. Fiellin |
| 59 |
[GO] |
2020―Oct―08 |
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas |
James Douglas Thornton, Tyler J. Varisco, Shweta S. Bapat, Callie G. Downs, Chan Shen |
| 60 |
[GO] |
2020―Oct―06 |
MOUD Provision in Correctional Settings During Time of COVID-19 |
Nickolas Zaller, Lauren Brinkley-Rubinstein |
| 61 |
[GO] |
2020―Oct―03 |
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs |
MJ Stowe, Tanya Calvey, Florian Scheibein, Sidharth Arya, Noha Ahmed Saad, Tomohiro Shirasaka, Lisa Dannatt, Abhishek Ghosh, Anne Yee, Woraphat Ratta-apha, Ramyadarshni Vadivel, Kristiana Siste, Bigya Shah, Rodrigo Ramalho, Venkata Lakshmi Narasimha, Mirjana Delic, Eric Peyron, Joy Louise Gumikiriza- Onoria, Sagun Ballav Pant, Saïd Boujraf, Paolo Grandinetti, Nirvana Morgan |
| 62 |
[GO] |
2020―Oct―03 |
Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing |
Jonathan Cantor, Bradley D. Stein, Brendan Saloner |
| 63 |
[GO] |
2020―Sep―20 |
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19 |
Christina A. Brezing, Sean X. Luo, John J. Mariani, Frances R. Levin |
| 64 |
[GO] |
2020―Sep―16 |
Preferences for Tobacco Cessation Information and Support During Covid-19 |
Simone Pettigrew, Min Jun, Ian Roberts, Chris Bullen, Kellie Nallaiah, Anthony Rodgers |
| 65 |
[GO] |
2020―Sep―09 |
The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries |
Tanya Calvey, Florian Scheibein, Noha Ahmed Saad, Tomohiro Shirasaka, Lisa Dannatt, MJ Stowe, Bigya Shah, Venkata Lakshmi Narasimha, Angelo Bruschi, Eric Peyron, Joy Louise Gumikiriza-Onoria, Abhishek Ghosh, Sagun Ballav Pant, Anne Yee, Woraphat Ratta-apha, Ramyadarshni Vadivel, Kristiana Siste, Tanay Maiti, Saïd Boujraf, Paolo Grandinetti, Nirvana Morgan, Sidharth Arya |
| 66 |
[GO] |
2020―Aug―30 |
Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons |
Sachini Bandara, Alene Kennedy-Hendricks, Sydney Merritt, Colleen L. Barry, Brendan Saloner |
| 67 |
[GO] |
2020―Aug―27 |
A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic |
Caroline P. Meehan, Rachel S. Wightman |
| 68 |
[GO] |
2020―Aug―21 |
Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond |
Coleman Drake, Jiani Yu, Nicole Lurie, Kevin Kraemer, Daniel Polsky, Krisda H. Chaiyachati |
| 69 |
[GO] |
2020―Aug―08 |
Opioid Use Disorder in the Emergency Department Amid COVID-19 |
Lauren A. Walter, Li Li |
| 70 |
[GO] |
2020―Aug―08 |
Calls for Access to Safe Injecting Supplies as a Critical Public Health Measure During the COVID-19 Pandemic |
Koharu Loulou Chayama, Cara Ng, Ryan McNeil |
| 71 |
[GO] |
2020―Jun―24 |
COVID-19 as a Frying Pan |
Brandon del Pozo, Leo Beletsky, Josiah D. Rich |
| 72 |
[GO] |
2020―Jun―11 |
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA |
Joshua A. Barocas, Elizabeth Blackstone, Tara C. Bouton, Simeon D. Kimmel, Andrea Caputo, Sarah J. Porter, Alexander Y. Walley |
| 73 |
[GO] |
2020―Jun―01 |
Will the Current COVID-19 Pandemic Impact on Long-Term Cannabis Buying Practices? |
Teodora Groshkova, Tiberiu Stoian, Andrew Cunningham, Paul Griffiths, Nicola Singleton, Roumen Sedefov |
| 74 |
[GO] |
2020―May―26 |
Low Barrier Tele-Buprenorphine in the Time of COVID-19 |
Miriam Harris, Samantha Johnson, Sarah Mackin, Richard Saitz, Alexander Y. Walley, Jessica L. Taylor |
| 75 |
[GO] |
2020―May―26 |
Gambling during the COVID-19 crisis - A cause for concern? |
Anders Håkansson, Fernando Fernández-Aranda, Jose M. Menchón, Marc N. Potenza, Susana Jiménez-Murcia |
| 76 |
[GO] |
2020―May―26 |
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond |
Corey S. Davis, Elizabeth A. Samuels |
| 77 |
[GO] |
2020―May―14 |
Innovation During COVID-19 |
Elizabeth A. Samuels, Seth A. Clark, Caroline Wunsch, Lee Ann Jordison Keeler, Neha Reddy, Rahul Vanjani, Rachel S. Wightman |
| 78 |
[GO] |
2020―May―14 |
Opioid Use Disorder and COVID-19 |
Utsha G. Khatri, Jeanmarie Perrone |
| 79 |
[GO] |
2020―May―14 |
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) |
Idris E. Leppla, Marielle S. Gross |
